• Users Online: 186
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Reader Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Most cited articles *

 
 
  Archives   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
REVIEW ARTICLES
Itraconazole: What clinicians should know?
Piet De Doncker, Sushil Pande, Ute Richarz, Nishant Garodia
January-June 2017, 3(1):4-10
DOI:10.4103/ijdd.ijdd_20_17  
  20 19,524 1,725
ORIGINAL ARTICLES
Tuberculin purified protein derivative immunotherapy in the treatment of viral warts
Ajay Nimbalkar, Sushil Pande, Ramesh Sharma, Milind Borkar
January-June 2016, 2(1):19-23
DOI:10.4103/2455-3972.184103  
  16 16,309 595
EDITORIAL
Clinical failure of antifungal therapy of dermatophytoses: Recurrence, resistance, and remedy
Ragunatha Shivanna, Arun C Inamadar
January-June 2017, 3(1):1-3
DOI:10.4103/ijdd.ijdd_13_17  
  9 11,457 1,023
ORIGINAL ARTICLES
Effect of measles mumps rubella vaccine in treatment of common warts
Anuja Dhope, Bhushan Madke, Adarsh Lata Singh
January-June 2017, 3(1):14-19
DOI:10.4103/ijdd.ijdd_1_17  
  8 15,327 501
EDITORIAL
Steroid containing fixed drug combinations banned by government of India: A big step towards dermatologic drug safety
Sushil Pande
January-June 2016, 2(1):1-2
DOI:10.4103/2455-3972.184102  
  6 11,134 354
REVIEW ARTICLE
Bilastine: A novel antihistamine
Jeet Gandhi, Kiran Godse, Gauri Godse
January-June 2018, 4(1):3-6
DOI:10.4103/ijdd.ijdd_12_18  
  6 26,101 1,547
Apremilast: A dermatologic perspective
Aditya Kumar Bubna
July-December 2016, 2(2):75-82
DOI:10.4103/2455-3972.196166  
  6 20,785 1,728
BRIEF REPORT
Successful use of oral acitretin in oral lichen planus
Ajay Deshpande
January-June 2017, 3(1):24-27
DOI:10.4103/ijdd.ijdd_9_17  
  4 8,847 208
LETTERS TO EDITOR
Azathioprine-induced alopecia as an early clinical marker of its myelotoxicity
Anil B Bhokare
January-June 2017, 3(1):40-41
DOI:10.4103/ijdd.ijdd_4_17  
  4 29,451 158
ORIGINAL ARTICLES
A study of clinical patterns and causative agents of adverse cutaneous drug reactions
Nilesh Mahatme, R Narasimharao
January-June 2016, 2(1):13-18
DOI:10.4103/2455-3972.184088  
  4 3,802 268
ALTERNATIVE MEDICINE
Homeopathic management of warts
Piyush Mahendra Oza
January-June 2016, 2(1):45-47
DOI:10.4103/2455-3972.184085  
  3 181,843 856
CASE REPORTS
Generalized bullous fixed drug reaction: A close similarity to stevens–johnson syndrome
Bhagyashri Daulatabadkar, Sushil Pande, Milind Borkar
January-June 2017, 3(1):28-31
DOI:10.4103/ijdd.ijdd_11_17  
  3 10,810 327
EDITORIAL
Tranexamic acid in melasma: Why and how?
Shuken Dashore, Katyain Mishra
July-December 2017, 3(2):61-63
DOI:10.4103/ijdd.ijdd_37_17  
  3 61,028 1,250
Topical sirolimus in the treatment of facial angiofibromas
Resham Vasani
July-December 2018, 4(2):49-51
DOI:10.4103/ijdd.ijdd_34_18  
  3 5,794 234
Biologics in psoriasis: Indian experience
Shrichand G Parasramani, Jisha Pillai
January-June 2019, 5(1):1-5
DOI:10.4103/ijdd.ijdd_33_19  
  3 14,074 732
ORIGINAL ARTICLES
Real-life efficacy and safety of secukinumab: A single-center, retrospective observational study with 52-week follow-up
Shekhar Neema, S Radhakrishnan, Sehdev Singh, Biju Vasudevan, Manas Chatterjee
January-June 2019, 5(1):14-18
DOI:10.4103/ijdd.ijdd_37_18  
  3 2,762 142
A clinical study of severe cutaneous adverse drug reactions and role of corticosteroids in their management
Rohini Sharma, Naina Dogra, Devraj Dogra
January-June 2017, 3(1):20-23
DOI:10.4103/ijdd.ijdd_22_16  
  3 3,546 213
BRIEF REPORT
Successful use of cyclosporine in the treatment of toxic epidermal necrolysis: A case series
Vikrant Saoji, Shilpa Hazare, Sanjiv Choudhary
January-June 2016, 2(1):24-27
DOI:10.4103/2455-3972.184089  
  2 6,920 222
CASE REPORTS
An alternative hepatosafe treatment in leprosy
Anuradha Ashok Bhide, Usha N Khemani, Ratnakar R Kamath, Varsha Vaidyanathan, Abhishek P Ponathil, Mahendra M Kura
January-June 2016, 2(1):33-36
DOI:10.4103/2455-3972.184086  
  2 10,531 452
EDITORIAL
Omalizumab in the treatment of chronic urticaria
Kiran Godse
January-June 2018, 4(1):1-2
DOI:10.4103/ijdd.ijdd_19_18  
  2 8,005 323
MANAGING A SIDE EFFECT
Oral retinoid-induced cheilitis
Bhushan Madke, Hiral Shah, Adarsh Lata Singh, Meenaz Khoja, Poonam Kabra
January-June 2016, 2(1):50-53
DOI:10.4103/2455-3972.184104  
  2 10,557 265
ORIGINAL ARTICLES
Intralesional bleomycin in the treatment of common warts
Mahesh Unni, Vaibhav Tapare
July-December 2017, 3(2):73-76
DOI:10.4103/ijdd.ijdd_26_17  
  2 10,443 294
Use of over-the-counter topical medications in dermatophytosis: A cross-sectional, single-center, pilot study from a tertiary care hospital
Rajeshwari Dabas, Manasa Shettisara Janney, Radhakrishnan Subramaniyan, Sandeep Arora, V Sandeep Lal, Navya Donaparthi
January-June 2018, 4(1):13-17
DOI:10.4103/ijdd.ijdd_5_18  
  2 5,429 270
TABLE
Maculopapular drug eruption versus maculopapular viral exanthem
Bhavana R Doshi, BS Manjunathswamy
January-June 2017, 3(1):45-47
DOI:10.4103/ijdd.ijdd_19_17  
  2 20,292 905
VIVA VOCE
Rituximab in the treatment of skin diseases
Murlidhar Rajagopalan, Resham Vasani
July-December 2017, 3(2):105-109
DOI:10.4103/ijdd.ijdd_31_17  
  2 6,815 501
* Source: CrossRef